Today Aetion and McKesson announced a strategic collaboration focused on advancing the use of real-world evidence (RWE) in cancer research to benefit patients, regulators, the biopharma industry and payers. The partnership will provide best-in-class solutions in multiple tumor types, including breast, lung and melanoma cancers.

top